What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals
Portfolio Pulse from Benzinga Insights
In the last quarter, ANI Pharmaceuticals (NASDAQ:ANIP) received 4 bullish ratings from analysts. The company's average 12-month price target is $66.0, with a high of $72.00 and a low of $60.00. This average price target has increased by 14.44% over the past month.
August 21, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ANI Pharmaceuticals received 4 bullish ratings from analysts in the last quarter. The average 12-month price target is $66.0, which has increased by 14.44% over the past month.
The bullish ratings and the increase in the average price target over the past month indicate a positive outlook for ANI Pharmaceuticals. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100